Invasive fungal infection in children with persistent febrile neutropenia
Related Experiment Video
Updated: Aug 18, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Hsin-Pao Lai1, Yee-Chun Chen, Luan-Yin Chang
1Department of Pediatrics, God's Help Hospital, Taipei, Taiwan.
Background And Purpose:
Children with persistent febrile neutropenia (fever > 96 hours) refractory to antibacterial therapy carry a high risk of invasive fungal infection (IFI). However, epidemiologic data in such patient populations is lacking in Taiwan.
Methods:
A retrospective study was conducted to identify risk factors and outcome of IFI in children with persistent febrile neutropenia (> 96 hours) hospitalized at National Taiwan University Hospital from January 1, 1999 through December 31, 1999. They were categorized into proven, probable, possible, or no IFI according to host, microbiologic and clinical criteria.
Results:
A total of 29 episodes (35.4%) of IFI occurred in 82 episodes of persistent febrile neutropenia and included 1 proven, 12 probable and 16 possible cases. Pneumonia was most common (69.0%), followed by disseminated infection (17.2%), paranasal sinusitis (6.9%), and hepatosplenic abscess (6.9%). Multivariate analysis revealed 4 risk factors independently associated with IFI: prolonged neutropenia (> 30 days; odds ratio [OR], 10.4; 95% confidence interval [CI], 1.8-60.5), prolonged steroid therapy (OR 2.0, 95% CI 1.0-10.8), allogeneic bone marrow transplantation (OR 5.3, 95% CI 1.0-28.0), and relapsed malignancy (OR 3.5, 95% CI 1.1-11.1). Patients with IFI carried higher in-hospital mortality than those without (51.7% vs 3.8%, p < 0.001). Among those with IFI, delayed antifungal therapy (persistent fever > 7 days) was associated with higher mortality rate than earlier treatment (73.3% vs 28.6%, p = 0.024) and was an independent adverse prognostic factor.
Conclusion:
IFI was common in patients with persistent febrile neutropenia and delayed antifungal therapy was an independent adverse prognostic factor.
Insights
Invasive fungal infections are common in children with persistent febrile neutropenia. Delayed antifungal therapy significantly increases mortality risk in these vulnerable pediatric patients.
Area of Science:
- Pediatric Infectious Diseases
- Hematology-Oncology
- Epidemiology
Background:
- Persistent febrile neutropenia in children, especially when refractory to antibiotics, poses a significant risk for invasive fungal infections (IFI).
- Limited epidemiologic data exists for IFI in this specific pediatric population in Taiwan.
Purpose of the Study:
- To identify the incidence, risk factors, and outcomes of invasive fungal infections (IFI) in children experiencing persistent febrile neutropenia.
- To analyze the impact of delayed antifungal therapy on mortality in this patient group.
Main Methods:
- A retrospective study analyzed 82 episodes of persistent febrile neutropenia in children at a major Taiwanese hospital.
- Infections were classified as proven, probable, or possible IFI based on established criteria.
- Multivariate analysis identified independent risk factors for IFI and assessed prognostic factors for mortality.
Main Results:
- Invasive fungal infections (IFI) occurred in 35.4% of persistent febrile neutropenia episodes, with pneumonia being the most frequent type.
- Independent risk factors for IFI included prolonged neutropenia (>30 days), extended steroid use, allogeneic bone marrow transplantation, and relapsed malignancy.
- Patients with IFI had a substantially higher in-hospital mortality rate (51.7% vs. 3.8%).
Conclusions:
- Invasive fungal infections (IFI) are a common and serious complication in children with persistent febrile neutropenia.
- Delayed antifungal therapy (fever >7 days) emerged as an independent adverse prognostic factor, significantly increasing mortality risk.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Fungal Phylum Microsporidia
Candidiasis
Rocky Mountain Spotted Fever
Bacterial Meningitis I: Introduction